Duchenne's Muscular Dystrophy (DMD) Withdrawn Phase 3 Trials for Deflazacort (DB11921)

Also known as: Duchenne's Muscular Dystrophy / Duchenne Muscular Dystrophy (DMD) / Duchenne Muscular Dystrophy / Muscular Dystrophy, Duchenne / Muscular dystrophy

IndicationStatusPhase
DBCOND0066749 (Duchenne's Muscular Dystrophy (DMD))Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03642145A Study of Deflazacort (Emflaza®) in Participants With Duchenne Muscular Dystrophy (DMD)Treatment